Novo Nordisk agreed to pay Omeros as much as $2.1 billion

Sănătate

Novo Nordisk agreed to pay Omeros as much as $2.1 billion for rights to an experimental rare-disease drug https://t.co/zRf6Xw1rSi

din zilele anterioare